Ono Pharmaceutical Statistics

Total Valuation

Ono Pharmaceutical has a market cap or net worth of JPY 754.35 billion. The enterprise value is 744.61 billion.

Market Cap	754.35B
Enterprise Value	744.61B

Important Dates

The next estimated earnings date is Monday, February 3, 2025.

Earnings Date	Feb 3, 2025
Ex-Dividend Date	Mar 28, 2025

Share Statistics

Ono Pharmaceutical has 469.71 million shares outstanding. The number of shares has decreased by -3.11% in one year.

Current Share Class	n/a
Shares Outstanding	469.71M
Shares Change (YoY)	-3.11%
Shares Change (QoQ)	-0.07%
Owned by Insiders (%)	0.05%
Owned by Institutions (%)	50.69%
Float	453.33M

Valuation Ratios

The trailing PE ratio is 7.97 and the forward PE ratio is 11.51.

PE Ratio	7.97
Forward PE	11.51
PS Ratio	1.57
PB Ratio	0.96
P/TBV Ratio	1.81
P/FCF Ratio	7.23
P/OCF Ratio	n/a
PEG Ratio	n/a

Financial Ratio History

Enterprise Valuation

The stock's EV/EBITDA ratio is 5.43, with an EV/FCF ratio of 7.14.

EV / Earnings	7.83
EV / Sales	1.54
EV / EBITDA	5.43
EV / EBIT	6.25
EV / FCF	7.14

Financial Position

The company has a current ratio of 3.22, with a Debt / Equity ratio of 0.21.

Current Ratio	3.22
Quick Ratio	2.52
Debt / Equity	0.21
Debt / EBITDA	1.18
Debt / FCF	1.55
Interest Coverage	33.25

Financial Efficiency

Return on equity (ROE) is 12.11% and return on invested capital (ROIC) is 8.55%.

Return on Equity (ROE)	12.11%
Return on Assets (ROA)	7.67%
Return on Capital (ROIC)	8.55%
Revenue Per Employee	125.69M
Profits Per Employee	24.69M
Employee Count	3,853
Asset Turnover	0.50
Inventory Turnover	2.37

Taxes

Income Tax	n/a
Effective Tax Rate	n/a

Stock Price Statistics

The stock price has decreased by -35.76% in the last 52 weeks.

Beta (5Y)	n/a
52-Week Price Change	-35.76%
50-Day Moving Average	1,825.57
200-Day Moving Average	2,124.35
Relative Strength Index (RSI)	22.27
Average Volume (20 Days)	2,230,890

Short Selling Information

Short Interest	n/a
Short Previous Month	n/a
Short % of Shares Out	n/a
Short % of Float	n/a
Short Ratio (days to cover)	n/a

Income Statement

In the last 12 months, Ono Pharmaceutical had revenue of JPY 484.30 billion and earned 95.13 billion in profits. Earnings per share was 201.49.

Revenue	484.30B
Gross Profit	365.06B
Operating Income	119.14B
Pretax Income	119.07B
Net Income	95.13B
EBITDA	137.19B
EBIT	119.14B
Earnings Per Share (EPS)	201.49

Full Income Statement

Balance Sheet

The company has 177.04 billion in cash and 161.66 billion in debt, giving a net cash position of 15.39 billion or 32.75 per share.

Cash & Cash Equivalents	177.04B
Total Debt	161.66B
Net Cash	15.39B
Net Cash Per Share	32.75
Equity (Book Value)	788.11B
Book Value Per Share	1,665.85
Working Capital	276.75B

Full Balance Sheet

Cash Flow

In the last 12 months, operating cash flow was 108.66 billion and capital expenditures -4.32 billion, giving a free cash flow of 104.35 billion.

Operating Cash Flow	108.66B
Capital Expenditures	-4.32B
Free Cash Flow	104.35B
FCF Per Share	222.15

Full Cash Flow Statement

Margins

Gross margin is 75.38%, with operating and profit margins of 24.60% and 19.64%.

Gross Margin	75.38%
Operating Margin	24.60%
Pretax Margin	24.59%
Profit Margin	19.64%
EBITDA Margin	28.33%
EBIT Margin	24.60%
FCF Margin	21.55%

Dividends & Yields

This stock pays an annual dividend of 80.00, which amounts to a dividend yield of 4.98%.

Dividend Per Share	80.00
Dividend Yield	4.98%
Dividend Growth (YoY)	3.90%
Years of Dividend Growth	3
Payout Ratio	39.83%
Buyback Yield	3.11%
Shareholder Yield	8.09%
Earnings Yield	12.55%
FCF Yield	13.83%

Dividend Details

Stock Splits

The last stock split was on March 29, 2016. It was a forward split with a ratio of 5.

Last Split Date	Mar 29, 2016
Split Type	Forward
Split Ratio	5

Scores

Ono Pharmaceutical has an Altman Z-Score of 4.85.

Altman Z-Score	4.85
Piotroski F-Score	n/a